Professor Kerry Courneya visited Ulster University last month to deliver two seminars in relation to physical activity and cancer, discussing it’s importance with some of the key stakeholders in Northern Ireland. Professor Courneya is the Canada Research Chair in the Faculty of Physical Education and Recreation at the University of Alberta in Edmonton, Canada. He is widely regarded as a world expert in the field of cancer and physical activity with research interests in the outcomes and determinants of physical activity, as well as behaviour change interventions. He is leading a global randomised control trial looking at a one year behaviour change intervention following a diabetes prevention protocol.
Professor Courneya delivered a seminar to academics and researchers entitled “Exercise & cancer outcomes: From observational studies to randomised trials”, where he presented the findings of many research projects which demonstrated an eclectic range of benefits for people living with cancer becoming and remaining active. The following day, Professor Courneya visited the Cancer Centre at Belfast City Hospital where he spoke enthusiastically about “Promoting physical activity in cancer survivors: From research to practice”. Drawing on his experience from working in Canada, Israel, Australia and many other countries throughout the world, Professor Courneya described the Macmillan Physical Activity Behaviour Change Care Pathway as ‘phenomenal’ and ‘world leading’. During his visit, Professor Courneya also took time out to meet with Macmillan’s Physical Activity Lead, Jo Foster, and Physical Activity Manager (Northern Ireland), Diarmaid McAuley. His endorsement of Macmillan’s approach will continue to inspire Macmillan to support people living with and beyond cancer to adopt and sustain an active lifestyle.
Professor Courneya’s visit to Northern Ireland was hosted by Ulster University’s Sport & Exercise Research Institute, the Institute for Nursing & Health Research, and the Belfast Health & Social Care Trust, with the support of Macmillan Cancer Support.